Effects of cilostazol on cognitive function and dementia risk: A systematic review and meta-analysis.

Medicine (Baltimore) · 2024 · PMC11651509 · PMID 39686486

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantP = .000not a probability at all

Effect of cilostazol on dementia risk Regarding the risk of dementia, cilostazol users had a marginally significant lower risk of dementia compared to the control group (pooled OR 0.90; 95% CI, 0.87 to 0.92; P = .000, I 2 = 40.7%) (Fig. 4 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.